Lumexa Imaging Holdings, Inc. (LMRI)

NASDAQ · Healthcare Services · Services-Medical Laboratories

Price
$10.52
Day
-1.50%
Market cap
$1.01B

Close 2026-09-22.

The company

Our Services Our proportionate revenue and volumes are highly diversified across a range of “advanced” (MRI, CT and positron emission tomography (“PET”)) and “routine” modalities (x-ray, ultrasound and mammography) of diagnostic and screening imaging services. For the year ended December 31, 2025, advanced imaging accounted for 52% of our consolidated revenue and 63% of our system-wide revenue. During the year ended December 31, 2025, MRI and CT accounted for 30% of our consolidated imaging volumes and 36% of our system-wide imaging volumes. Our Strengths National Outpatient Imaging Platform Focused on Advanced Modalities and Attractive MSAs We are the second largest provider of outpatient imaging services in the country by number of centers, with a national footprint predominantly located in attractive MSAs.

From Item 1: Our Services · Our Strengths.

Institutional holders

Largest positions reported on Form 13F for the quarter ended 2026-06-30, by value.

Insider trades

Open-market buys and sales filed on Form 4, newest first. Grants, option exercises and tax withholding are left out.

Recent filings